Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation

Department of Hematology, Hospital Clinic of Barcelona, Institut d'Investigacions Biomediques August Pi i Sunyer, Faculty of Medicine, University of Barcelona, Spain.

BACKGROUND AND OBJECTIVES: Three single nucleotide polymorphisms (SNP) in the NOD2/CARD15 gene have been associated with the incidence and the severity of acute graft-versus-host disease (GVHD) following allogeneic stem cell transplantation (SCT). We hypothesized that the clinical effect of SNP in NOD2/CARD15 might be different in patients submitted to T-cell-depleted allogeneic SCT, in which donor T cells, the main effectors of GVHD, are eliminated. DESIGN AND METHODS: SNP 8, 12 and 13 in NOD2/CARD15 were studied using a Taqman protocol in 85 patients undergoing HLA-identical, T-cell-depleted SCT and in 71 of their sibling donors. RESULTS: NOD2/CARD15 variants were present in nine (11%) patients and six (8%) donors. The incidences of acute GVHD and chronic GVHD were not associated with either the donors' or recipients' NOD2/CARD15 variants. In contrast, these genetic variants were associated with a lower disease-free survival (17% vs. 48%, p=0.03). Death due to pulmonary infection was more frequent in the group of patients with NOD2/CARD15 variants. In the multivariate analysis, only NOD2/CARD15 variants (RR 2.3, p=0.04) and older age (RR 2.2; p=0.04) were independent prognostic factors for disease-free survival. INTERPRETATION AND CONCLUSIONS: NOD2/CARD15 variants have a deleterious effect on clinical outcome in T-cell-depleted allogeneic SCT, which is independent of GVHD. These results supports the hypothesis that the detrimental effect of NOD2/CARD15 variants in such a transplant setting might be produced by an alteration of the innate immune system more than by activation of the adaptive immune system.

This article has been cited by other articles:

				M. Granell, A. Urbano-Ispizua, A. Pons, J. I. Arostegui, B. Gel, A. Navarro, S. Jansa, R. Artells, A. Gaya, C. Talarn, et al. Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation Blood, November 15, 2008; 112(10): 4337 - 4342. [Abstract] [Full Text] [PDF]

				E. Holler, J. Hahn, R. Andreesen, G. Rogler, J. Brenmoehl, H. Greinix, A. M. Dickinson, G. Socie, D. Wolff, and J. Finke NOD2/CARD15 Polymorphisms in Allogeneic Stem-Cell Transplantation From Unrelated Donors: T Depletion Matters J. Clin. Oncol., January 10, 2008; 26(2): 338 - 339. [Full Text] [PDF]

				N. P. Mayor, B. E. Shaw, D. A. Hughes, H. Maldonado-Torres, J. A. Madrigal, S. Keshav, and S. G.E. Marsh In Reply J. Clin. Oncol., January 10, 2008; 26(2): 339 - 339. [Full Text] [PDF]

				N. P. Mayor, B. E. Shaw, D. A. Hughes, H. Maldonado-Torres, J. A. Madrigal, S. Keshav, and S. G.E. Marsh Single Nucleotide Polymorphisms in the NOD2/CARD15 Gene Are Associated With an Increased Risk of Relapse and Death for Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation With Unrelated Donors J. Clin. Oncol., September 20, 2007; 25(27): 4262 - 4269. [Abstract] [Full Text] [PDF]